Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
Company overview

Sdiptech Q2: Group EBITA* 95% above forecast

Redeye Research Note timeStamp 2020/07/22

Redeye sees an excellent Q2-report, where all segments vastly outperformed our EBITA* forecasts. The margin was boosted by cost cuts and solid demand in scalable businesses. Organic growth was -2% and the business model has surely proven itself. We will most likely raise our forecasts and Base case. However, the share price has increased significantly, and we will get back to our updated view on the share in our Q2 update.

  • All three segments far better than expected – group EBITA* 95% above forecast
  • High margin due to a mix of sustainable and unsustainable cost reductions
  • SEK 5.7m in government support on the group level
  • Expect to catch up delayed orders in 2020 and 2021
  • Raised margin guidance for SIS regarding 2020 to 22-25% (20-22)
  • The target of 5-10% organic EBITA* growth in 2020 remains – now seems reasonable given strong H1
  • We will most likely increase our forecasts and Base case

Fredrik Nilsson

Fredrik Nilsson

Equity Analyst

Tagged companies
  • Office
  • Mäster Samuelsgatan 42, 10th floor
  • Box 7141, 103 87
  • Stockholm, Sweden
  • info@redeye.se
  • +46 (0)8 545 013 30
  • Services
  • Home
  • Research
  • Transactions
  • Events
  • Redeye
  • Community
  • Members Home
  • Premium
  • Legal
  • Terms and conditions (Swedish)
  • Terms of membership (Swedish)
  • Terms and conditions - Advisory (Swedish)
  • Terms and conditions - Advisory (English)
  • Integrity Policy (Swedish)
  • Disclaimer (Swedish)
  • Governance
  • Follow
  • Twitter
  • Facebook
  • LinkedIn
  • Redeye
  • At a Glance
  • Our Culture
  • Investor Services
  • Corporate Broking
  • Corporate Finance
  • Newsroom
  • The Team
  • Careers
  • FAQ

© All rights reserved. Redeye AB is authorised and regulated by the Swedish Financial Supervisory Authority, Finansinspektionen. 2021

You need to be a Redeye member to access this content

Become a member to:

  • Access all our extensive research on 100+ Nordic Tech and Life Science companies
  • Make smarter investment decisions with the guidance of our experienced analysts
  • Receive exciting offers to participate in IPO’s and other transactions

    By clicking "Sign up" you indicate that you read and agree to our Terms & Conditions

    I already have an account and want to sign in